Posted April 3, 2020
The United States Food and Drug Administration (FDA) has reported its first shortage of a drug in the United States due to the novel coronavirus (COVID-19) outbreak that began in China in December 2019 and, by March 11, 2020, had been declared a global pandemic by the World Health Organization (WHO). Read more.